The authors of Li-Yu D. Liu, Li-Yun Chang, Wen-Hung Kuo et al. Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system. *Cancer Informatics*. 2014;13:21--45. doi: 10.4137/CIN.S12493. recently brought to the attention of the Editor in Chief, Dr. J. T. Efird, corrections they wished to make to the paper. The Editor in Chief reviewed these with reference to applicable Committee on Publication Ethics guidelines and determined that publication of a separate corrigendum was an appropriate response to the authors' request. The authors' full statement is given hereafter.

We, as the authors of the paper "Prognostic features of signal transducer and activator of transcription 3 in an ER (+) breast cancer model system", published in Cancer Informatics 2014:13 21--45, wish to correct [Figures 3F](#f1-cin-13-2014-125){ref-type="fig"}, [7A, 7B](#f2-cin-13-2014-125){ref-type="fig"}, [S6.2--6.3, S7.1--7.5](#s1-cin-13-2014-125){ref-type="supplementary-material"} and [Tables 2](#t1-cin-13-2014-125){ref-type="table"}, [3](#t2-cin-13-2014-125){ref-type="table"}.

We made unexpected mistakes during generating genome-wide data of 90th percentile Kaplan-Meier survival analysis on the gene of interest using R package. We have generated multiple sets of survival curves beginning with the earlier publications. To the best of our knowledge, all of them are correct except for 72 A cohort and a few data in 90 A cohort in this paper. The new [Figure 3F](#f1-cin-13-2014-125){ref-type="fig"}, [Tables 2](#t1-cin-13-2014-125){ref-type="table"}--[3](#t2-cin-13-2014-125){ref-type="table"} and [Figures S6.2--6.3](#s1-cin-13-2014-125){ref-type="supplementary-material"} have the corrected data, marked in red in [Tables 2](#t1-cin-13-2014-125){ref-type="table"}--[3](#t2-cin-13-2014-125){ref-type="table"}.

Additionally, we have made new [Figures 7A and B](#f2-cin-13-2014-125){ref-type="fig"} to replace the old ones to be consistent with the original text.

In some instances, the text of the article also reflects errors in the data, and is hereby corrected as follows:

Page 23, right column.

This sentence from the original article:

> Kaplan-Meier survival analyses^21^ were done using the "survival" package in R (version 2.15.1) for the gene profiles of 90 A cohort, 91 A cohort, 181 A cohort or the extracted gene pools of interest in the assigned cohorts.

is corrected to read as follows:

> Kaplan-Meier survival analyses^21^ were done using the "survival" package in R (version 2.15.1) for the gene profiles of 90 A cohort, 72 A cohort, 181 A cohort or the extracted gene pools of interest in the assigned cohorts.

Page 30, legends of [tables 2](#t1-cin-13-2014-125){ref-type="table"} and [3](#t2-cin-13-2014-125){ref-type="table"}

To be consistent with new [Figure 3F](#f1-cin-13-2014-125){ref-type="fig"}, the legend of [Table 2](#t1-cin-13-2014-125){ref-type="table"} from the original article:

> [Table 2](#t1-cin-13-2014-125){ref-type="table"}. The prognostic values for inferred target genes of *STAT3* and *MYC* in the 90 A cohort.

is corrected to read as follows:

> [Table 2](#t1-cin-13-2014-125){ref-type="table"}. The prognostic values for inferred target genes of *STAT3* and *MYC* or of *\*STAT3* in the 90 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"}).

To be consistent with new [Figure 3F](#f1-cin-13-2014-125){ref-type="fig"}, the legend of [Table 3](#t2-cin-13-2014-125){ref-type="table"} from the original article:

> [Table 3](#t2-cin-13-2014-125){ref-type="table"}. The prognostic values for inferred target genes of *STAT3* and *MYC* in the 72 A cohort.

is corrected to read as follows:

> [Table 3](#t2-cin-13-2014-125){ref-type="table"}. The prognostic values for inferred target genes of *STAT3* and *MYC* or of *\*STAT3* in the 72 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"}).

Page 31, right column.

This sentence from the original article:

> High levels of *IDH3G* are a favorable prognosis predictor in 72 A cohort ([Table 3](#t2-cin-13-2014-125){ref-type="table"}).

should be regarded as deleted.

Page 35, left column

This sentence from the original article:

> Surprisingly, *STAT3* regulates 59% (60/101) of ERBB2 signaling molecules in the 90 A cohort.

is corrected to read as follows:

> Surprisingly, *STAT3* regulates 59% (60/101) of ERBB2 signaling molecules in the 90 A cohort (Table S4.12).

This sentence from the original article:

> The expression patterns of these signaling molecules shown in heatmaps ([Fig. 7B](#f2-cin-13-2014-125){ref-type="fig"}) indicate that *STAT3* mediated regulation of these 6 signaling molecules (*PRKCB1*, *MAP2K4*, *NRG1*, *NCK2*, *ABL1* and *GRB2*) provides a good prognostic indicator in the 90 A cohort ([Table 2](#t1-cin-13-2014-125){ref-type="table"}).

is corrected to read as follows:

> The expression patterns of these signaling molecules shown in heatmaps ([Fig. 7B](#f2-cin-13-2014-125){ref-type="fig"}) indicate that *STAT3* mediated regulation of these 5 signaling molecules (*MAP2K4*, *NRG1*, *NCK2*, *ABL1* and *GRB2*) provides a poor prognostic indicator in the 90 A cohort ([Table 2](#t1-cin-13-2014-125){ref-type="table"}).

Page 36, left column

> This sentence from the original article: For instance, we found the expression levels of *GRB2*, *NCK2*, *STAT3*, *PRKCB1*, *MAP2K4*, *ABL1*, *IGF2R*, *LYN*, and *VEGFA* in the *STAT3* network to be predictors for poor clinical outcome in the 90 A cohort.

is corrected to read as follows:

> For instance, we found the expression levels of *NANOG*, *GRB2*, *NCK2*, *STAT3*, *PRKCB1*, *MAP2K4*, *ABL1*, *IGF2R*, *LYN*, and *VEGFA* in the *STAT3* network to be predictors for poor clinical outcome in the 90 A cohort.

This sentence from the original article:

> Alternately, the expression levels of *NANOG*, *OIP5*, *LDHB*, *NRG1* and *POU5F1* in the *STAT3* network are predicted to be good prognostic factors in the 90 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 2](#t1-cin-13-2014-125){ref-type="table"}).

is corrected to read as follows:

> Alternately, the expression levels of *OIP5*, *LDHB*, *NRG1* and *POU5F1* in the *STAT3* network are predicted to be good prognostic factors in the 90 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 2](#t1-cin-13-2014-125){ref-type="table"}).

This sentence from the original article:

> Moreover, there are 6 poor and 5 good prognostic factors in the *STAT3* network of 72 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 3](#t2-cin-13-2014-125){ref-type="table"}).

is corrected to read as follows:

> Moreover, there are 8 poor and 4 good prognostic factors in the *STAT3* network of 72 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 3](#t2-cin-13-2014-125){ref-type="table"}).

Page 37, right column

This sentence from the original article:

> We found 9 poor prognostic factors and 5 good prognostic factors of the *STAT3* network in the 90 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 2](#t1-cin-13-2014-125){ref-type="table"}).

is corrected to read as follows:

> We found 10 poor prognostic factors and 4 good prognostic factors of the *STAT3* network in the 90 A cohort ([Fig. 3F](#f1-cin-13-2014-125){ref-type="fig"} and [Table 2](#t1-cin-13-2014-125){ref-type="table"}).

Page 41, right column

These sentences from the original article:

> It contains relatively high levels of *GRB2*, *LYN*, *IGF2R*, *VEGFA*, *STAT3*, *NCK2*, *OIP5* and *ABL1* and low levels of *MAP2K4*, *PRKCB*, *POU5F1* and *NRG1*, indicating poor prognosis. Low levels of *LDHB* and *NANOG* predict good prognosis.

are corrected to read as follows:

> It contains relatively high levels of *GRB2*, *LYN*, *IGF2R*, *VEGFA*, *STAT3*, *NCK2*, *OIP5* and *ABL1* and low levels of *MAP2K4*, *PRKCB*, *POU5F1*, *NRG1* and *NANOG*, indicating poor prognosis. Relative low levels of *LDHB* predict good prognosis.

Supplementary Files
===================

Please also view the Supplementary Files PDF, which contains corrected versions of [Supplementary Figures S6.2--S6.3 and S7.1--S7.5](#s1-cin-13-2014-125){ref-type="supplementary-material"}.
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  GENE SYMBOL (FEATURE NO.)   INCREASED EXPRESSION LEVEL   P VALUE   PATHWAYS
  --------------------------- ---------------------------- --------- --------------------------------------------
  ABL1 (8019)                 poor prognosis               0.046     ERBB2, PDGFRB, cell cycle and angiogenesis
  IGF2R (1723)                poor prognosis               0.048     angiogenesis
  PRKCB1 (6676)               good prognosis               0.033     ERBB2 and VEGF
  MAP2 K4 (18964)             good prognosis               0.034     ERBB2
  NRG1 (11559)                good prognosis               0.011     ERBB2
  LYN (19236)                 poor prognosis               0.001     PDGFRB and angiogenesis
  STAT3 (4386)                poor prognosis               0.028     PDGFRB and angiogenesis
  STAT3 (15013)               poor prognosis               0.002     PDGFRB and angiogenesis
  VEGFA (1135)                poor prognosis               0.02      VEGF and angiogenesis
  VEGFA (15367)               poor prognosis               0.008     VEGF and angiogenesis
  OIP5 (16433)                poor prognosis               0.013     FOXC1 network
  NCK2 (3851)                 poor prognosis               0.029     ERBB2 and PDGFRB
  LDHB (20259)                poor prognosis               0.038     Warburg effect
  GRB2 (16731)                poor prognosis               0.019     ERBB2 and PDGFRB
  \*NANOG (C12928.2)          good prognosis               0.024     EMT
  POU5F1 (6057)               good prognosis               0.02      EMT
  GRB2 (1952)                 poor prognosis               0.03      ERBB2 and PDGFRB

  GENE SYMBOL   REGULATION STATUS   BIOCHEMICAL PATHWAY         PROGNOSIS   REGULATORS
  ------------- ------------------- --------------------------- ----------- ---------------
  GRB2          up                  ERBB2 and PDGFRB            poor        MYC and STAT3
  CDKN1A        up                  p53, cell cycle and ERBB2   poor        MYC and STAT3
  ARAF          up                  ERBB2                       poor        MYC and STAT3
  NCK2          up                  ERBB2 and PDGFRB            poor        MYC and STAT3
  PAK6          up                  ERBB2                       good        MYC and STAT3
  KRAS          up                  ERBB2 and VEGF              good        MYC and STAT3
  STAT3         up                  PDGFRB and angiogenesis     poor        MYC and STAT3
  ELK1          up                  FOXC1 network and ERBB2     good        MYC and STAT3
  OIP5          down                FOXC1 network               good        MYC and STAT3
  \*NRAS        up                  ERBB2                       poor        STAT3
  LYN           up                  PDGFRB and angiogenesis     poor        MYC and STAT3
  VEGFA         up                  angiogenesis                poor        MYC and STAT3

[^1]: \*These authors contributed equally to this work.
